Health Care: Drugs

Acasti Pharma Inc (ACST: NASDAQ)

$1.37 n/a | n/a%
06/24/16 - 03:29 PM ET
Company Cash Flow
Feb 2016 Feb 2015 Feb 2014 Feb 2013
Cash Flow From Operating Activities
Net Income (Loss) -4.66M -1.32M -10.44M -6.73M
Operating Gains/Losses 27.05K 1.28K 0.00 0.00
Extraordinary Gains / Losses n.a. 0.00 0.00 0.00
(Increase) Decrease In Receivables 336.30K 236.49K -282.47K 241.06K
(Increase) Decrease in Inventories 64.47K 139.18K -35.33K 368.58K
(Increase) Decrease In Other Current Assets n.a. 0.00 0.00 0.00
(Decrease) Increase In Payables -329.85K 361.07K -78.23K 1.16M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items -1.95M -7.35M 3.74M 1.80M
Net Cash From Continuing Operations -4.85M -5.76M -6.12M -2.49M
Net Cash From Discontinued Operations n.a. 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -4.85M -5.76M -6.12M -2.49M
Sale of Property, Plant & Equipment n.a. 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 15.08M 17.71M 5.39M 1.95M
Purchases of Property, Plant & Equipment -271.25K -68.70K -133.56K -100.68K
Acquisitions n.a. 0.00 0.00 0.00
Purchases of Short-Term Investments -8.82M -11.58M -22.82M 0.00
Other Cash from Investing Activities 83.92K 32.78K 88.19K 1.74K
Cash Provided by Financing Activities
Net Cash From Investing Activities 6.07M 6.10M -17.48M 1.85M
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 461.00 39.98K 873.74K 224.15K
Repayment of Long-Term Debt 0.00 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -2.25K -3.25K 21.56M -2.62K
Net Cash From Financing Activities -1.79K 36.73K 22.44M 221.53K
Effect of Exchange Rate Changes 47.78K 127.97K 689.10K 29.45K
Net Change in Cash & Cash Equivalents 1.27M 507.82K -468.32K -384.12K
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter